Physician profile
Harold Hsu
NPI 1770508111
$1,654.08
in general payments reported to CMS, 2019-2025
18 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $156 · 2021: $470 · 2022: $347 · 2023: $63.61 · 2024: $106 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288 · Education: $28.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.14 |
| Education | $28.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $752.91 | 2019-2022 | |
| Novo Nordisk INC | $147.23 | 2019-2025 | Ozempic, Rybelsus |
| W. L. Gore & Associates, INC. | $133.24 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.66 | 2022-2025 | Jardiance |
| Astellas Pharma US INC | $74.99 | 2019 | |
| Abbvie INC. | $67.11 | 2021-2025 | |
| Glaxosmithkline, LLC. | $56.79 | 2021-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $44.11 | 2023-2025 | Mounjaro, Jardiance |
| Sun Pharmaceutical Industries INC. | $42.40 | 2020 | |
| Amgen INC. | $31.01 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $30.30 | 2019 | |
| Ironwood Pharmaceuticals, INC | $28.72 | 2024 | |
| Radius Health, INC. | $28.04 | 2019 | |
| Dexcom, INC. | $27.58 | 2023 | Dexcom G6 Transmitter |
| Inari Medical, INC. | $25.94 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $20.27 | 2022 | |
| Gilead Sciences, INC. | $16.97 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.